Medical Oncology

Urologic Oncology

Questions discussed in this category

What could explain the contradictory results between CheckMate 274 and IMVIGOR 010?

Does this raise concerns about the efficacy of adjuvant immune checkpoint inhibition? Are any preliminary results from AMBASSADOR (adjuvant pembrolizu...

3 Answers available

Would you recommend adjuvant nivolumab for patients with upper tract urothelial cancer?

The forest plot from CheckMate 274 did not show a benefit for such patients? How would you select between adjuvant chemotherapy and adjuvant nivoluma...

1 Answer available

When is the ideal time to start adjuvant nivolumab after radical surgery in urothelial carcinoma?

Is a 3 month delay too long in someone who had postoperative complications?

2 Answers available

For urothelial carcinoma with squamous differentiation, what chemotherapy do you give for chemoradiation?

2 Answers available

Is there an absolute PSA level above which you would not recommend a radical prostatectomy for newly diagnosed prostate cancer despite the absence of metastatic disease with advanced imaging?

Are there other high or very high risk features that would also contribute to your decision making?

1 Answer available

Would you recommend surgery or radiation for newly diagnosed localized prostate cancer diagnosed on a urethral lesion biopsy?

GS 4+4. PSA low (1-2). CT and bone scan negative for lymphadenopathy or metastatic disease. Prostate MRI pending.

2 Answers available

Would you continue pembrolizumab in a patient with BCG-refractory NMIBC with CIS who has a negative surveillance cystoscopy (including random biopsies) but positive urine cytology?

1 Answer available

Would you use pembrolizumab to treat patients with BCG-refractory Ta or T1 NMIBC without CIS?

2 Answers available

For a patient who is cisplatin-eligible with localized, high-grade upper tract urothelial carcinoma, but no muscularis propria seen on biopsy, what is your approach?

What neoadjuvant or adjuvant therapy would you give?

1 Answer available

Would you skip adjuvant RT in post prostatectomy patients?

Based on the RADICALS-RT trial presented at ESMO, can RT be omitted in post op prostate patients in favor of salvage RT? If not which group of patient...

6 Answers available

Do you offer bladder-sparing approaches as an alternative to cystectomy for surgery-eligible patients with muscle-invasive bladder cancer?

Should cystectomy remain standard of care? (Recently debated in JAMA Oncology: http://jamanetwork.com/journals/jamaoncology/article-abstract/2520055...

1 Answer available